Aggregated price index with volume information
Summary:
- Generic Drug Makers stocks up 1.9% on average while median return up 1.8% in a day
- Generic Drug Makers stocks up 1.5% on average while median return up 2.8% in a week
- Generic Drug Makers stocks up 9.0% on average while median return up 9.2% in a month
- When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.
Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.
- 1M winners are : Winners for past month are $ACRS 25.2%, $EGRX 16.3%, $AMRX 15.0%, $COLL 13.4%, $RDY 12.8%
- 1M losers are : Losers for past month are $ANIP -3.4%, $BHC -11.8%
- 1W winners are : Winners for past week are $COLL 11.5%, $AMPH 7.2%, $ACRS 5.3%, $CHRS 4.9%, $RDY 4.0%
- 1W losers are : Losers for past week are $EGRX -2.6%, $BHC -21.2%
Correlation Analysis
Index correlation analysis
Correlation for the past month is 9.2%, for the past 3 months is 6.4%
In the past month for a 5 days rolling window, the highest corrrelation is 24.0%, the lowest correlation is -2.7%, the latest correlation is 21.6%
When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.
Among pairwise correlation, the highest correlation is 55.8% between AMPH and COLL
The lowest correlation is -51.6% between PRGO and RDY
Perrigo (PRGO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Bausch (BHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here is how Aclaris Therapeutics (ACRS) and Adma Biologics (ADMA) have performed compared to their sector so far this year.
STOUGHTON, Mass., July 25, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced that it will report second quarter 2024 financial results after the market closes on Thursday, August 8, 2024. Following the release of the financials, the Company will host a live conference call and webcast at 4:30 p.m. ET. Conference Call Info
PARSIPPANY, N.J. & PARIS, July 25, 2024--Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) and Sanofi today announced an update to the timing for the anti-TL1A, duvakitug (formerly known as TEV-’574/SAR447189) program investigating the human IgG1-λ2 monoclonal antibody targeting TL1A for moderate-to-severe IBD.
It was a busy day for shares of Bausch Health Companies, which were cut nearly in half before recovering as it addressed a report saying it was mulling bankruptcy options.
LAVAL, QC / ACCESSWIRE / July 24, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company") has become aware of a news article issued by Reorg® today, citing unnamed sources. The article contains unsubstantiated rumors, including that ...
Investing.com - Bausch Health Companies Inc (NYSE:BHC) shares shed 23.3% on Wednesday following an unconfirmed report from Reorg.com that the company is negotiating a potential prepackaged Chapter 11 bankruptcy filing to help deleverage its balance sheet.
Bausch + Lomb (BLCO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
O’keefe Stevens Advisory, an investment advisory firm, released its second-quarter 2024 investor letter. A copy of the same can be downloaded here. Ongoing expectations of near-term rate reduction drove a 3.9% gain in the S&P 500, and companies like Nvidia led this. In the first half, Microsoft, Alphabet, Amazon, and Meta increased by more than […]